We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Volatile substance abuse.
Volatile substance abuse (VSA) (glue sniffing, inhalant abuse, solvent abuse), the deliberate inhalation of volatile substances in order to achieve intoxication, has now been reported from most parts of the world, mainly among adolescents, individuals living in remote communities and those whose occupations give ready access to abusable substances. Solvents from contact adhesives, notably toluene, petrol (gasoline), halogenated solvents, volatile hydrocarbons such as those found in cigarette lighter refills, aerosol propellants, halocarbon fire extinguishers, and inhalational anaesthetics may be abused in this way. VSA gives rise to dose-related effects similar to those of other hypnosedatives. Small doses can rapidly lead to euphoria and other disturbances of behaviour similar to those caused by ethanol (alcohol), and may also induce delusions and hallucinations. Higher doses may produce life-threatening effects such as convulsions and coma. Death may ensue indirectly after, for example, inhalation of vomit, or from direct cardiac or central nervous system toxicity. Chronic abuse of toluene-containing products and of chlorinated solvents such as 1,1,1-trichloroethane, for example, can produce severe organ damage, especially in the liver, kidneys, and brain. Drunken behaviour, unexplained listlessness, anorexia and moodiness may result from VSA, especially in children and adolescents. The hair, breath and clothing may smell of solvent, and empty adhesive tubes or other containers, potato crisp bags, cigarette lighter refills, and aerosol spray cans are often found. Toxicological examination of blood and tissue specimens is especially important in confirming a diagnosis of sudden VSA-related death. The development and evaluation of strategies for the treatment of chronic abusers and for prevention are major challenges for the future.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app